Join
Live feed
·
PRReleasevia Quantisnow
Dyadic International Inc. logo

Dyadic Highlights Accelerated Interest in C1 Biomanufacturing Platform Amid Ebola Preparedness Activities and Growing Commercial Adoption

ByQuantisnow·Wall Street's wire, on your screen.
DYAI· Dyadic International Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DYAI (Dyadic International Inc.) and more on Quantisnow.